VIVEX Biologics, Inc. Sustainability Profile
VIVEX Biologics, Inc., headquartered in the United States, is a pioneering leader in the regenerative medicine industry. Founded in 2015, the company has rapidly established itself as a key player in the development and distribution of innovative biologic solutions, primarily focusing on orthopaedic and wound care applications. VIVEX's core offerings include advanced allograft tissues and cellular therapies, which are distinguished by their commitment to quality and efficacy. The company’s unique approach to tissue preservation and processing sets it apart in a competitive market, ensuring optimal outcomes for patients. With a strong presence across major operational regions in North America, VIVEX Biologics has achieved significant milestones, including partnerships with leading healthcare institutions. Its dedication to advancing regenerative medicine continues to solidify its position as a trusted provider in the field.
DitchCarbon Score
How does VIVEX Biologics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
VIVEX Biologics, Inc.'s score of 18 is lower than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
VIVEX Biologics, Inc.'s reported carbon emissions
VIVEX Biologics, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that VIVEX may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives at this time. As the company operates within the biologics sector, it may face increasing pressure to adopt sustainable practices and transparency in emissions reporting in line with broader industry trends.
How Carbon Intensive is VIVEX Biologics, Inc.'s Industry?
How Carbon Intensive is VIVEX Biologics, Inc.'s Location?
VIVEX Biologics, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
VIVEX Biologics, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Smith Plus Nephew
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.